WallStSmart

America Movil SAB de CV ADR (AMX)vsSurgepays Inc (SURG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

America Movil SAB de CV ADR generates 1873202% more annual revenue ($943.64B vs $50.37M). AMX leads profitability with a 8.8% profit margin vs -83.4%. SURG appears more attractively valued with a PEG of 0.53. AMX earns a higher WallStSmart Score of 69/100 (B-).

AMX

Strong Buy

69

out of 100

Grade: B-

Growth: 4.0Profit: 7.0Value: 10.0Quality: 4.0
Piotroski: 6/9Altman Z: 1.37

SURG

Hold

39

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMXUndervalued (+67.3%)

Margin of Safety

+67.3%

Fair Value

$72.07

Current Price

$24.76

$47.31 discount

UndervaluedFair: $72.07Overvalued

Intrinsic value data unavailable for SURG.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMX5 strengths · Avg: 8.8/10
Free Cash FlowQuality
$42.68B10/10

Generating 42.7B in free cash flow

Market CapQuality
$70.61B9/10

Large-cap with strong market position

Return on EquityProfitability
20.5%9/10

Every $100 of equity generates 21 in profit

P/E RatioValuation
15.2x8/10

Attractively priced relative to earnings

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

SURG1 strengths · Avg: 8.0/10
PEG RatioValuation
0.538/10

Growing faster than its price suggests

Areas to Watch

AMX4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Price/BookValuation
72.8x2/10

Trading at 72.8x book value

Altman Z-ScoreHealth
1.372/10

Distress zone — elevated risk

SURG4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.9%4/10

2.9% revenue growth

Market CapQuality
$19.68M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-3.1%2/10

ROE of -3.1% — below average capital efficiency

EPS GrowthGrowth
-77.7%2/10

Earnings declined 77.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMX

The strongest argument for AMX centers on Free Cash Flow, Market Cap, Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : SURG

The strongest argument for SURG centers on PEG Ratio. PEG of 0.53 suggests the stock is reasonably priced for its growth.

Bear Case : AMX

The primary concerns for AMX are Revenue Growth, EPS Growth, Price/Book. Debt-to-equity of 2.53 is elevated, increasing financial risk.

Bear Case : SURG

The primary concerns for SURG are Revenue Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

AMX profiles as a value stock while SURG is a turnaround play — different risk/reward profiles.

AMX carries more volatility with a beta of 0.37 — expect wider price swings.

AMX is growing revenue faster at 3.4% — sustainability is the question.

AMX generates stronger free cash flow (42.7B), providing more financial flexibility.

Bottom Line

AMX scores higher overall (69/100 vs 39/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

America Movil SAB de CV ADR

COMMUNICATION SERVICES · TELECOM SERVICES · USA

Amrica Mvil, SAB de CV provides telecommunications services in Latin America and internationally. The company is headquartered in Mexico City, Mexico.

Visit Website →

Surgepays Inc

COMMUNICATION SERVICES · TELECOM SERVICES · USA

SurgePays, Inc., provides telecommunications services in the United States. The company is headquartered in Bartlett, Tennessee.

Want to dig deeper into these stocks?